CLOSE X

RUBICON RESEARCH LTD.

NSE : RUBICONBSE : 544578ISIN CODE : INE506V01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE1671.90-59.4 (-3.43 %)
PREV CLOSE ( ) 1731.30
OPEN PRICE ( ) 1730.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16456
TODAY'S LOW / HIGH ( )1663.55 1730.25
52 WK LOW / HIGH ( )571 1896.15
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 06-05 1999
Management Info
Venkat Changavalli - Chairman Pratibha Pilgaonkar - Managing Director
Registered Office

Address Medone House, B-75,Road No. 33,Wagle Estate, Thane (West),
Thane,
Maharashtra-400604

Phone 022- 61414000 / 50414000

Email secretarial@rubicon.co.in / reachus@rubicon.co.in

Website www.rubicon.co.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
29Aug Rubicon Research informs about disclos
Rubicon Research has informed thatit encloseddisclosure under Regulation..
27Aug Rubicon Research informs about disclo
Rubicon Research has informed that the exchange has received the disclos..
27Aug General Atlantic sells 8.4% stake in R
The US-based global investment firm General Atlantic, through its affili..
23Jul Rubicon Research soars on acquiring ma
Rubicon Research is currently trading at Rs. 1515.00, up by 50.10 points..
22Jul Rubicon Research acquires manufacturin
Rubicon Research has acquired manufacturing facility in East Brunswick,..
Financials
Rs. in Millions
QTR Jun 26 ANNUAL 26
Net Profit824.491881.65
Gross Profit 1106.57 2527.79
Operating Profit 1272.383214.87
Net Sales 4277.313060.82
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27223.20 (0.96%)
M.Cap ( in Cr)57847.40
NGL Fine-Chem (BSE)
 2846.65 (4.25%)
M.Cap ( in Cr)1758.67
Haleos Labs (BSE)
 1533.00 (4.44%)
M.Cap ( in Cr)463.47
Sudeep Pharma (BSE)
 1198.85 (4.77%)
M.Cap ( in Cr)13540.85
Mankind Pharma (BSE)
 2479.40 (2.04%)
M.Cap ( in Cr)102410.40
Shareholding Pattern
PROMOTERS 59.76%
NON-INSTITUTION 23.3%
MUTUAL FUNDS/UTI 7.23%
FI/BANKS/INSURANCE 0.18%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
No Data Found
Advisory for Investors Complaints Data August 2026 Broking Complaints Data August 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002
  • 6)Verified UPI ID for receiving Payments: badjate.rzp1.brk@validhdfc
  • 7)Click here for QR Code

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.